Lundbeck to present pipeline developments for amlenetug in multiple system atrophy at MDS Congress 2025
H. Lundbeck A/S (Lundbeck) today announced that pipeline developments regarding amlenetug, a novel investigational molecule for the potential treatment of Multiple System Atrophy (MSA), will be presented at… read more.
